http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2009000035-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b755982699e3ea5199d569ee5f5344c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-00
filingDate 2009-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4c9704f705e4809aced60518ed7d6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125c76105ada417dd162bb8e8581b32c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bae188cb6965bf7aa8077d5f22028439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30fd61eb5fda045c945ebd2d3be0fc93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b1b2da8657cbc9c781329681ae8c539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27ccb3099c35a1fec3388ded90e5a68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb21123b08ecf51a48a3ac6a2bd54ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f8548a7919d73c6289d74ee243ac141
publicationDate 2009-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2009000035-A1
titleOfInvention Derived compounds 3-spiro-heterocyclo-1yl-5h-cyclopentan [d] pyrimidine-indole, useful for inhibiting the activity of akt kinase; pharmaceutical composition comprising said compounds; and use in the treatment of diseases such as cancer, cystic fibrosis, diabetes, Alzheimer's disease, among others.
abstract Derived compounds 3-spiro-heterocyclo-1yl-5h-cyclopentan [d] pyrimidine-indole, useful for inhibiting the activity of akt kinase; pharmaceutical composition comprising said compounds; pharmaceutical kit; and use in the treatment of diseases such as cancer, cystic fibrosis, diabetes, Alzheimer's, among others.
priorityDate 2008-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448811262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67426066

Total number of triples: 49.